Malin Corporation
Malin Corporation plc is an Irish public limited company established in 2015, with its headquarters in Dublin and additional offices in New Haven, Connecticut, and Research Triangle, North Carolina. The company specializes in venture capital investments, focusing on innovative enterprises within the life sciences and healthcare technology sectors, particularly in oncology, immunology, and genetic diseases. Malin's strategy involves the selective application of capital and operational expertise to support private, pre-IPO, and pre-trade sale businesses in rapidly growing markets. By actively engaging with its investee companies, Malin aims to enhance their value propositions and facilitate their journey toward commercial success.
Past deals in Connecticut
Artizan Biosciences
Venture Round in 2017
Artizan Biosciences, Inc. is a biotechnology company focused on developing small molecule drugs for human use, particularly targeting diseases linked to intestinal inflammation. Founded in 2016 and headquartered in New Haven, Connecticut, the company employs its proprietary IgA-SEQ technology platform to identify and characterize disease-driving bacteria within the intestinal microbiota. This innovative approach aims to create precision therapeutics that address the root causes of various serious conditions, including digestive disorders, obesity, autoimmune diseases, and a range of other health issues affecting the skin, lungs, and central nervous system. By focusing on unmet medical needs, Artizan Biosciences seeks to provide novel treatment options for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.